About H. Lundbeck A

Company Description

Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries. We are tirelessly dedicated to restoring brain health, so every person can be their best. 

Research into the brain costs more, takes longer and fails at a higher rate than most other medical research. But with brain disorders sharply on the increase, it’s more important than ever. We are one of the only global pharmaceutical companies solely focused on the brain, and our research programs tackle some of the most complex challenges in neuroscience. Our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.

Year founded

1915

Served area

Worldwide

Headcount

5,300

Headquarters

Ottiliavej 9, 2500 Valby – Denmark

Shareholder information

Shares outstanding

199,148,222

IPO

Jan. 1, 2000

Stock exchange(s)

Nasdaq Copenhagen

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.